ArticleBritish journal of pharmacology2018

Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.

Weijun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.